Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGillessen, Silke
dc.contributor.authorBossi, Alberto
dc.contributor.authorDavis, Ian D.
dc.contributor.authorFizazi, Karim
dc.contributor.authorJames, Nicholas D.
dc.contributor.authorMateo Valderrama, Joaquim
dc.contributor.authorde Bono, Johann S
dc.date.accessioned2023-04-21T13:14:04Z
dc.date.available2023-04-21T13:14:04Z
dc.date.issued2023-03
dc.identifier.citationGillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, et al. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. Eur Urol. 2023 Mar;83(3):267–93.
dc.identifier.issn0302-2838
dc.identifier.urihttps://hdl.handle.net/11351/9392
dc.descriptionTratamiento hormonal; Cáncer de próstata; Efectos secundarios
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesEuropean Urology;83(3)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPròstata - Càncer - Tractament
dc.subjectPròstata - Càncer - Diagnòstic
dc.subjectDecisió, Presa de
dc.subject.meshProstatic Neoplasms
dc.subject.mesh/therapy
dc.subject.meshConsensus
dc.titleManagement of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.eururo.2022.11.002
dc.subject.decsneoplasias de la próstata
dc.subject.decs/terapia
dc.subject.decsconsenso
dc.relation.publishversionhttps://doi.org/10.1016/j.eururo.2022.11.002
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Gillessen S] Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. Università della Svizzera Italiana, Lugano, Switzerland. [Bossi A] Genitourinary Oncology, Prostate Brachytherapy Unit, Gustave Roussy, Paris, France. [Davis ID] Monash University and Eastern Health, Victoria, Australia. [de Bono J] The Institute of Cancer Research, London, UK. Royal Marsden Hospital, London, UK. [Fizazi K] Institut Gustave Roussy, University of Paris Saclay, Villejuif, France. [James ND] The Institute of Cancer Research, London, UK. [Mateo J] Prostate Cancer Translational Research Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid36494221
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple